Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
58 studies found for:    primary-progressive multiple sclerosis
Show Display Options
Rank Status Study
21 Unknown  Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
Conditions: Primary Progressive Multiple Sclerosis;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: Andrographolides;   Drug: placebo
22 Recruiting A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Secondary Progressive;   Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Relapse Free
Interventions: Drug: masitinib;   Drug: placebo
23 Recruiting A LOW-COST VIRTUAL REALITY GAMING PLATFORM FOR NEUROREHABILITATION OF HEMIPARESIS
Conditions: Primary Progressive Multiple Sclerosis;   Hemiparesis
Intervention: Behavioral: Gaming CI Therapy
24 Recruiting Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Conditions: Relapsing-remitting Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis;   Primary-progressive Multiple Sclerosis
Interventions: Drug: estriol;   Other: Placebo;   Drug: Norethindrone;   Other: Progestin Placebo
25 Recruiting Mitochondrial Dysfunction and Disease Progression
Conditions: Clinically Isolated Syndrome;   Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Primary Progressive Multiple Sclerosis
Intervention:
26 Completed Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity
Condition: Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
27 Terminated Cannabis for Spasticity in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Inhaled Cannabis;   Drug: Oral THC;   Drug: Placebo
28 Terminated Cannabis for Spasticity in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Smoked Cannabis
29 Recruiting ACTH in Progressive Forms of MS
Conditions: Secondary Progressive Multiple Sclerosis;   Primary Progressive Multiple Sclerosis;   Progressive Relapsing Multiple Sclerosis
Interventions: Drug: ACTH;   Drug: Placebo
30 Active, not recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
31 Not yet recruiting MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Personal history of multiple sclerosis
32 Recruiting Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients
Conditions: Multiple Sclerosis;   Systemic Sclerosis
Intervention: Other: Blood sample collection
33 Terminated Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Prednisone;   Drug: Placebo
34 Completed Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina
Condition: Multiple Sclerosis
Intervention:
35 Completed Wahls Paleo Diet and Progressive Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Other: Wahls Paleo Plus;   Other: Wahls Diet
36 Terminated Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: Trap Myelin Test
37 Active, not recruiting Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: MD1003 100mg capsule
38 Recruiting The French Multiple Sclerosis Registry
Conditions: Multiple Sclerosis;   Neuromyelitis Optica Spectrum Disorders
Intervention:
39 Completed Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Conditions: Multiple Sclerosis (MS);   Relapsing-Remitting MS;   Primary Progressive MS;   Secondary Progressive MS;   Clinically Isolated Syndrome (CIS)
Intervention: Other: No study treatments administered - blood draws only
40 Recruiting Imaging of Intracerebral Inflammation in MS
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Secondary Progressive;   Multiple Sclerosis, Primary Progressive
Intervention: Drug: 18F-DPA-714 and 18F-FDG

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.